Boston Scientific shares tumble as cyberattack disrupts global operations and shipments

Boston Scientific disclosed in an SEC 8-K that it identified a cybersecurity incident on August 25, 2026, disrupting IT systems used to process and ship customer orders. Shares fell in premarket trading Wednesday, though reports vary: Insurance Journal put the decline at 3.5% and Yahoo Finance at 4%. More than 7,000 staff across the company's Irish plants, including Cork, were told to work from home as the outage entered a second day, and the company says it has not yet determined whether the incident will be material to its financials.

Boston Scientific (BSX) disclosed in an SEC Form 8-K filed August 26, 2026 that it identified a cybersecurity incident affecting certain of its information technology systems on August 25, 2026. The filing says the incident has disrupted the company's ability to process and ship customer orders, and that "the timeline for a full restoration is not yet known." Boston Scientific also said it has not yet determined whether the incident is reasonably likely to have a material impact on the company, and that its investigation is ongoing.

The outage has forced staff at Boston Scientific's Irish operations to work remotely. More than 7,000 employees across the company's three Irish plants, in Cork, Clonmel and Galway, were informed Tuesday, August 25, of the global network outage, and Cork's Model Farm Road site, which employs an estimated 1,200 people, sent its day-shift staff home with full pay. As of Wednesday's coverage, the outage had entered its second day.

Shares fell in premarket trading Wednesday following the disclosure, though reported figures differ: Insurance Journal put the premarket decline at 3.5%, while Yahoo Finance reported a 4% premarket drop the same morning. Both outlets note that Boston Scientific has not yet determined the full scope of the incident or whether it could ultimately have a material impact on the business. The stock was already down sharply for the year heading into this incident: TipRanks tracked a roughly 47.7% year-to-date decline and a "Sell" technical sentiment signal.

Insurance Journal framed the incident as part of a broader wave of recent cyberattacks in the healthcare sector, also citing Abbott Laboratories, Stryker, Medtronic, health insurer Clover Health, Novo Nordisk and West Pharmaceutical Services as recent targets. Boston Scientific said it activated its incident response process, including engaging third-party cybersecurity experts, as the investigation continues. What happens next could hinge on how quickly the company can restore order-processing systems and whether it discloses a material financial impact; until then, the scope and duration of the disruption remain officially unresolved.

Related Stocks

Powered by SentiSense - Intelligent Market Analysis